Short Interest in Enzon Pharmaceuticals, Inc. (OTCMKTS:ENZN) Increases By 406.3%

Enzon Pharmaceuticals, Inc. (OTCMKTS:ENZN) saw a significant growth in short interest in the month of December. As of December 31st, there was short interest totalling 8,100 shares, a growth of 406.3% from the December 15th total of 1,600 shares. Based on an average trading volume of 356,600 shares, the short-interest ratio is presently 0.0 days.

Enzon Pharmaceuticals Trading Down 0.1 %

ENZN traded down $0.00 during midday trading on Wednesday, reaching $0.13. The company’s stock had a trading volume of 7,032 shares, compared to its average volume of 92,676. The company has a fifty day simple moving average of $0.12 and a 200 day simple moving average of $0.13. The stock has a market cap of $9.64 million, a P/E ratio of 13.00 and a beta of 0.27. Enzon Pharmaceuticals has a twelve month low of $0.06 and a twelve month high of $0.24.

About Enzon Pharmaceuticals

Enzon Pharmaceuticals, Inc, together with its subsidiaries, does not have significant operations. Previously, the company marketed its patented drug product, PegIntron. It also had a marketing agreement with Micromet AG relating to the Vicineum drug; and a licensing agreement regarding SC Oncaspar and certain other drugs.